The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Calcium and Cardiomyopathies
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Many of the proteins involved in this cycle have been implicated in cardiac failure, the leading cause of death world-wide (3, 4).”
In the citing paper
“SERCA and PLN are key proteins within this tightly regulated process (3) and have been identified as potential drug targets (34, 35).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular basis of abnormal calcium transients of failing human ventricular myocytes
Piacentino, V., Weber, C. R., Chen, X., Weisser-Thomas, J., Margulies, K. B., Bers, D. M., & Houser, S. R. (2003) · Circulation Research · doi:10.1161/01.res.0000062469.83985.9b · Cited by 477
Self-citationPogwizd, S. M., Qi, M., Yuan, W., Samarel, A. M., & Bers, D. M. (1999) · Circulation Research · doi:10.1161/01.res.85.11.1009 · Cited by 399
Self-citation
Research works printed but not linked: 76
- Anderson, M.E., Braun, A.P., Schulman, H., et al., 1994, Multifunctional Ca 2+ /calmodulin-dependent protein kinase mediates Ca(2+)-induced enhancement of the L-type Ca 2+ current in rabbit ventricular myocytes. Circ Res, 75(5), pp854–61. · DOI · Paper page
- Bassani, J.W., Yuan, W., andBers, D.M., 1995, Fractional SR Ca release is regulated by trigger Ca and SR Ca content in cardiac myocytes. Am J Physiol, 268(5 Pt 1), ppC1313–9. · DOI · Paper page
- Bers, D.M., 2001,Excitation-Contraction Coupling and Cardiac Contractile Force. 2nd ed: Kluwer Academic Press, Boston, Massachusetts. · DOI · Paper page
- Bossuyt, J., Ai, X., Moorman, J.R., et al., 2005, Expression and phosphorylation of the na-pump regulatory subunit phospholemman in heart failure. Circ Res, 97(6), pp558–65. · DOI
- Brittsan, A.G., andKranias, E.G., 2000, Phospholamban and cardiac contractile function. J. Mol. Cell. Cardiol., 32, pp2131–2139. · DOI · Paper page
- Dash, R., Frank, K.F., Carr, A.N., et al., 2001, Gender influences on sarcoplasmic reticulum Ca 2+ -handling in failing human myocardium. J Mol Cell Cardiol, 33(7), pp1345–53. · DOI · Paper page
- Dash, R., Kadambi, V., Schmidt, A.G., et al., 2001, Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality. Circulation, 103(6), pp889–96. · DOI
- de Tombe, P.P., 1998, Altered contractile function in heart failure. Cardiovasc Res, 37(2), pp367–80. · DOI
- del Monte, F., Harding, S.E., Schmidt, U., et al., 1999, Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a. Circulation, 100, pp2308–11. · DOI · Paper page
- Desai, K.H., Schauble, E., Luo, W., et al., 1999, Phospholamban deficiency does not compromise exercise capacity. Amer. J. Physiol, 276(4), ppH1172–7.
- Farrell, E.F., Antaramian, A., Rueda, A., et al., 2003, Sorcin inhibits calcium release and modulates excitation-contraction coupling in the heart. J Biol Chem, 278, pp34660–66. · DOI
- Franz, W.M., Muller, O.J., andKatus, H.A., 2001. Cardiomyopathies: from genetics to the prospect of treatment. Lancet, 358, pp1627–1637. · DOI · Paper page
- Garvey, J.L., Kranias, E.G., andSolaro, R.J., 1988, Phosphorylation of C-protein, troponin I and phospholamban in isolated rabbit hearts. Biochem J, 249(3), pp709–14. · DOI · Paper page
- Ginsburg, K.S., andBers, D.M., 2004, Modulation of excitation-contraction coupling by isoproterenol in cardiomyocytes with controlled SR Ca load and I_Ca trigger. J Physiol, 556(Pt 2), pp463–80. · DOI · Paper page
- Go, L.O., Moschella, M.C., Watras, J., et al. 1995, Differential regulation of two types of intracellular calcium release channels during end-stage heart failure. J Clin Invest, 95(2), pp888–94. · DOI · Paper page
- Guo, T., Zhang, T., Mestril, R., Bers, D.M., 2006, Ca/Calmodulin-Dependent Protein Kinase II Phosphorylation of Ryanodine Receptor Does Affect Calcium Sparks in Mouse Ventricular Myocytes. Circ Res, 99(4), pp398–406. · DOI · Paper page
- Gyorke, I., Hester, N., Jones, L.R., Gyorke, S., 2004, The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium. Biophys J., 86(4), pp2121–8. · DOI · Paper page
- Hasenfuss, G. 1998, Alterations of calcium-regulatory proteins in heart failure. Cardiovasc Res, 37(2), pp279–89. · DOI · Paper page
- Hobai, I.A., O’Rourke, B. 2001, Decreased sarcoplasmic reticulum calcium content is responsible for defective excitation-contraction coupling in canine heart failure. Circulation, 103(11), pp1577–84. · DOI · Paper page
- Hoit, B.D., Khoury, S.F., Kranias, E.G., et al., 1995, In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. Circ Res,77(3), pp632–7. · DOI · Paper page
- Houser, S.R., Piacentino, V. 3rd., Mattiello, J., et al., 2000, Functional properties of failing human ventricular myocytes. Trends Cardiovasc Med, 10(3), pp101–7. · DOI
- Huang, B., Wang, S., Qin, D., et al., 1999, Diminished basal phosphorylation level of phospholamban in the postinfarction remodeled rat ventricle: role of beta-adrenergic pathway, G(i) protein, phosphodiesterase, and phosphatases. Circ Res, 85(9), pp848–55. · DOI
- Kadambi, V.J., Ponniah, S., Harrer, J.M., et al., 1996, Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice. J Clin Invest, 97(2), pp533–9. · DOI · Paper page
- Kentish, J.C., McCloskey, D.T., Layland, J., et al. 2001, Phosphorylation of troponin I by protein kinase A accelerates relaxation and crossbridge cycle kinetics in mouse ventricular muscle. Circ Res, 88(10), pp1059–65. · DOI · Paper page
- Kranias, E.G., andSolaro, R.J., 1982, Phosphorylation of troponin I and phospholamban during catecholamine stimulation of rabbit heart. Nature, 298(5870), pp182–4. · DOI · Paper page
- Kranias, E.G., Steenaart, N.A., andDi Salvo, J., 1988, Purification and characterization of phospholamban phosphatase from cardiac muscle. J Biol Chem, 263(30), pp15681–7. · DOI
- Leenhardt, A., Lucet, V., Denjoy, I., et al., 1995, Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation, 91(5), pp1512–9. · DOI · Paper page
- Lehnart, S.E., Wehrens, X.H., Laitinen, P.J., et al., 2004, Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak. Circulation, 109(25), pp3208–14. · DOI · Paper page
- Li, L., Chu, G., Kranias, E.G., et al., 1998, Cardiac myocyte calcium transport in phospholamban knockout mouse: relaxation and endogenous CaMKII effects. Am J Physiol, 274(4 Pt 2), ppH1335–47.
- Li, L., Desantiago, J., Chu, G., et al., 2000, Phosphorylation of phospholamban and troponin I in beta-adrenergic-induced acceleration of cardiac relaxation. Am J Physiol Heart Circ Physiol, 278(3), ppH769–79. · DOI · Paper page
- Li, L., Satoh, H., Ginsburg, K.S., et al., 1997, The effect of Ca(2+)-calmodulin-dependent protein kinase II on cardiac excitation-contraction coupling in ferret ventricular myocytes. J Physiol. 501(Pt 1), pp17–31. · DOI · Paper page
- Li, Y., Kranias, E.G., Mignery, G.A., et al., 2002, Protein kinase A phosphorylation of the ryanodine receptor does not affect calcium sparks in mouse ventricular myocytes. Circ Res, 90(3), pp309–16. · DOI · Paper page
- Lindemann, J.P., Jones, L.R., Hathaway, D.R., et al., 1983, beta-Adrenergic stimulation of phospholamban phosphorylation and Ca 2+ -ATPase activity in guinea pig ventricles. J Biol Chem, 258(1), pp464–71. · DOI · Paper page
- Lindner, M., Erdmann, E., andBeuckelmann, D.J., 1998, Calcium content of the sarcoplasmic reticulum in isolated ventricular myocytes from patients with terminal heart failure. J Mol Cell Cardiol, 30(4), pp743–9. · DOI · Paper page
- Lorenz, J.N., andKranias, E.G., 1997, Regulatory effects of phospholamban on cardiac function in intact mice. Am J Physiol, 273(6 Pt 2), ppH2826–31.
- Luo, W., Grupp, I.L., Harrer, J., et al., 1994, Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation. Circ Res, 75(3), pp401–9. · DOI · Paper page
- Luo, W., Wolska, B.M., Grupp, I.L., et al., 1996, Phospholamban gene dosage effects in the mammalian heart. Circ Res, 78(5), pp839–47. · DOI
- Luo, W., Chu, G., Sato, Y., et al., 1998, Transgenic approaches to define the functional role of dual site phospholamban phosphorylation. J. Biol. Chem., 273, pp4734–4739. · DOI
- MacLennan, D.H., andKranias, E.G., 2003, Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol, 4(7), pp566–77. · DOI · Paper page
- Maier, L.S., Zhang, T., Chen, L., et al., 2003, Transgenic CaMKIIdeltaC overexpression uniquely alters cardiac myocyte Ca 2+ handling: reduced SR Ca 2+ load and activated SR Ca 2+ release. Circ Res, 92(8), pp904–11. · DOI · Paper page
- Marx, S.O., Reiken, S., Hisamatsu, Y. et al., 2000, PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell, 101(4), pp365–76. · DOI · Paper page
- McCall, E., Li, L., Satoh, H., et al., 1996, Effects of FK-506 on contraction and Ca 2+ transients in rat cardiac myocytes. Circ Res, 79(6), pp1110–21. · DOI
- McTiernan, C.F., Frye, C.S., Lemster, B.H., et al., 1999, The human phospholamban gene: structure and expression. J. Mol. Cell. Cardiol, 31, pp679–692. · DOI
- Minamisawa, S., Sato, Y., Tatsuguchi, et al., 2003, Mutation of the phospholamban promoter associated with hypertrophic cardiomyopathy. Biochem Biophys Res Commun, 304(1), pp1–4. · DOI
- Mitchell, R.D., Simmerman, H.K., andJones, L.R., 1988, Ca 2+ binding effects on protein conformation and protein interactions of canine cardiac calsequestrin. J Biol Chem, 263(3), pp1376–81. · DOI · Paper page
- Miyamoto, M.I., del Monte, F., Schmidt, U., et al., 2000, Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci U S A, 97(2), pp793–8. · DOI · Paper page
- Mukherjee, R., andSpinale, F.G., 1998, L-type calcium channel abundance and function with cardiac hypertrophy and failure: a review. J Mol Cell Cardiol, 30(10), pp1899–916. · doi:10.1006/jmcc.1998.0755
- Mundina-Weilenmann, C., Vittone, L., Ortale, M., et al. 1996, Immunodetection of phosphorylation sites gives new insights into the mechanisms underlying phospholamban phosphorylation in the intact heart. J Biol Chem, 271(52), pp33561–7. · DOI
- Nabauer, M., andKaab, S., 1998, Potassium channel down-regulation in heart failure. Cardiovasc Res, 37(2), pp324–34. · DOI · Paper page
- Phillips, R.M., Narayan, P., Gomez, A.M., et al., 1998, Sarcoplasmic reticulum in heart failure: central player or bystander? Cardiovasc Res, 37(2), pp346–51. · DOI
- Pi, Y., Kemnitz, K.R., Zhang, D., et al., 2002, Phosphorylation of troponin I controls cardiac twitch dynamics: evidence from phosphorylation site mutants expressed on a troponin I-null background in mice. Circ Res, 90(6), pp649–56. · DOI
- Pogwizd, S.M., Schlotthauer, K., Li, L., et al., 2001, Arrhythmogenesis and contractile dysfunction in heart failure: Roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness. Circ Res., 88(11), pp1159–67. · DOI · Paper page
- Richard, S., Leclercq, F., Lemaire, S., et al., 1998, Ca 2+ currents in compensated hypertrophy and heart failure. Cardiovasc Res, 37(2), pp300–11. · DOI
- Sainte, Beuve C., Allen, P.D., Dambrin, G., et al., 1997, Cardiac calcium release channel (ryanodine receptor) in control and cardiomyopathic human hearts: mRNA and protein contents are differentially regulated. J Mol Cell Cardiol., 29(4), pp1237–46. · DOI
- Sato, Y., Kiriazis, H., Yatani, A., et al., 2001, Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablation. J. Biol. Chem., 276(12), pp9392–9, · DOI
- Schillinger, W., Meyer, M., Kuwajima, G., et al., 1996, Unaltered ryanodine receptor protein levels in ischemic cardiomyopathy. Mol Cell Biochem, 160–161, pp297–302. · DOI
- Schmidt, A.G., Haghighi, K., Frank, B., et al., 2003, Polymorphic SERCA2a variants do not account for inter-individual differences in phospholamban –SERCA2a interaction in human heart failure. J. Mol. Cell. Cardiol, 35, pp867–870. · DOI
- Schmitt, J.P., Kamisago, M., Asahi, M., et al., 2003, Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science, 299(5611), pp1410–1413. · DOI · Paper page
- Schwinger, R.H., Munch, G., Bolck, B., et al., 1999, Reduced Ca(2+)-sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation. J Mol Cell Cardiol, 31(3), pp479–91. · DOI · Paper page
- Shannon, T.R., Ginsburg, K.S., andBers, D.M., 2000, Potentiation of fractional sarcoplasmic reticulum calcium release by total and free intra-sarcoplasmic reticulum calcium concentration. Biophys J, 78(1), pp334–43. · DOI · Paper page
- Simmerman, H.K., andJones, L.R., 1998, Phospholamban: protein structure, mechanism of action, and role in cardiac function. Physiol Rev, 78(4), pp921–47. · DOI · Paper page
- Solaro, R.J., andBriggs, F.N., 1974, Estimating the functional capabilitities of sarcoplasmic reticulum in cardiac muscle. Circ. Res., 34, pp531–540. · doi:10.1161/01.res.34.4.531
- Stange, M., Xu, L., Balshaw, D., et al., 2003, Characterization of recombinant skeletal muscle (Ser-., 2843) and cardiac muscle (Ser-., 2809) ryanodine receptor phosphorylation mutants. J Biol Chem, 278(51), pp51693–702. · doi:10.1074/jbc.m310406200
- Talosi, L., Edes. I., andKranias, E.G., 1993, Intracellular mechanisms mediating reversal of beta-adrenergic stimulation in intact beating hearts. Am J Physiol, 264(3 Pt 2), ppH791–7.
- Valdivia, H.H., Kaplan, J.H., Ellis-Davies, G.C., et al., 1995, Rapid adaptation of cardiac ryanodine receptors: modulation by Mg2+ and phosphorylation. Science, 267, pp997–2000. · DOI · Paper page
- Vatner, D.E., Sato, N., Kiuchi, K., et al., 1994, Decrease in myocardial ryanodine receptors and altered excitation-contraction coupling early in the development of heart failure. Circulation, 90(3), pp1423–30. · DOI
- Wang, J., Maertz, N.A., Lokua, A.J., et al., 2001, Regulation of cardiac Ryanodine Receptors activity by calsequestrin. Biophys J, 80, pp590a. · DOI
- Wegener, A.D., Simmerman, H.K., Lindemann, J.P., et al., 1989, Phospholamban phosphorylation in intact ventricles. Phosphorylation of serine 16 and threonine 17 in response to beta-adrenergic stimulation. J Biol Chem, 264(19), pp11468–74. · DOI · Paper page
- Wehrens, X.H., Lehnart, S.E., Huang, F., et al., 2003, FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell, 113(7), pp829–40. · DOI · Paper page
- Wickenden, A.D., Kaprielian, R., Kassiri, Z., et al., 1998, The role of action potential prolongation and altered intracellular calcium handling in the pathogenesis of heart failure. Cardiovasc Res, 37(2), pp312–23. · DOI · Paper page
- Wolska, B.M., Stojanovic, M.O., Luo, W., et al., 1996, Effect of ablation of phospholamban on dynamics of cardiac myocyte contraction and intracellular Ca 2+ . Am J Physiol, 271(1 Pt 1), ppC391–7. · DOI · Paper page
- Xiao, B., Sutherland, C., Walsh, M.P., et al. 2004, Protein kinase A phosphorylation at serine-2808 of the cardiac Ca 2+ -release channel (ryanodine receptor) does not dissociate 12.6-kDa FK506-binding protein (FKBP12.6). Circ Res, 94(4), pp487–95. · DOI · Paper page
- Xiao, R.P., Cheng, H., Lederer, W.J., et al. 1994, Dual regulation of Ca 2+/calmodulin-dependent kinase II activity by membrane voltage and by calcium influx. Proc Natl Acad Sci U S A. 91(20), pp9659–63. · DOI · Paper page
- Yano, M., Ono, K., Ohkusa, T., et al. 2000, Altered stoichiometry of FKBP12.6 versus ryanodine receptor as a cause of abnormal Ca(2+) leak through ryanodine receptor in heart failure. Circulation, 102(17), pp2131–6. · doi:10.1161/01.cir.102.17.2131
- Yuan, W., Bers, D.M. 1994, Ca-dependent facilitatiosn of cardiac Ca current is due to Ca-calmodulin-dependent protein kinase. Am J Physiol. 267(3 Pt 2), ppH982–93.
- Zhang, L., Kelley, J., Schmeisser, G., et al. 1997, Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane. J Biol Chem, 272(37), pp23389–97. · DOI · Paper page
Cited by
Calcium Pumps in Health and Disease
Brini, M., & Carafoli, E. (2009) · Physiological Reviews · doi:10.1152/physrev.00032.2008 · Cited by 676
Paredes, R. M., Etzler, J. C., Watts, L. T., Zheng, W., & Lechleiter, J. D. (2008) · Methods · doi:10.1016/j.ymeth.2008.09.025 · Cited by 610
Heart Failure With Preserved Ejection Fraction: Mechanisms, Clinical Features, and Therapies
Sharma, K., & Kass, D. A. (2014) · Circulation Research · doi:10.1161/circresaha.115.302922 · Cited by 508
Endoplasmic-Reticulum Calcium Depletion and Disease
Mekahli, D., Bultynck, G., Parys, J. B., De Smedt, H., & Missiaen, L. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004317 · Cited by 478
Wen, Y., Alshikho, M. J., & Herbert, M. R. (2016) · PLOS ONE · doi:10.1371/journal.pone.0153329 · Cited by 150
Metadata
- Authors
- KRANIAS, E. G., & BERS, D. M.
- Venue
- Subcellular Biochemistry
- Publisher
- Springer Netherlands
- Published
- 2007
- Pages
- 523-537
- Cited by
- 89
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Calcium and Cardiomyopathies. https://app.cochat.ai/papers/10.1007/978-1-4020-6191-2_20
- The paper
- KRANIAS, E. G., & BERS, D. M. (2007). Calcium and Cardiomyopathies. Subcellular Biochemistry. https://doi.org/10.1007/978-1-4020-6191-2_20
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.